- Degree Programs
- Application Process
- Frequently Asked Questions
- Track and Pathway Programs
Merck has announced that the U.S. FDA has approved Zinplava™ to reduce recurrence of C. diff infection. The drug was developed by researchers at MassBiologics in conjunction with Medarex (now part of Bristol-Myers Squibb), and licensed to Merck in 2009.Read more
Welcome to Admissions at the University of Massachusetts School of Medicine. As the Associate Dean of Admissions of this wonderful school, I thank you for visiting our website. I hope you will spend some time exploring our admissions process, academic and degree programs and student resources. I hope you find it informative regardless of your current level of engagement in the medical school admissions process. I am certain that you will get a sense of the strong and caring community that characterizes our School. I would like to call your attention to two recent and exciting changes. Beginning in 2015, the School of Medicine accepts applicants who are not Massachusetts residents. Also, this year the Population-based Urban and Rural Health (PURCH) Pathway - a partnership between the School of Medicine and Baystate Health - is accepting its first cohort of students. Please contact the Admissions Office if we can be of assistance to you.